Zolmitriptan
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
46708-182 -
Package NDC
46708-182-03 -
Application number
ANDA205074 -
SPL ID
052016e5-acea-4d2a-8d76-cef36eb99262 -
SPL set ID
b8d657ac-dbda-4455-8bb5-3896951c3b67 -
UNII
2FS66TH3YW -
RxCUI
284201 -
RxCUI
351134
What the source publishes
- Labeler
- Alembic Pharmaceuticals Limited
- Active ingredients
- Zolmitriptan
- Form
- TABLET, ORALLY DISINTEGRATING
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Zolmitriptan",
"splId": "052016e5-acea-4d2a-8d76-cef36eb99262",
"labels": [
{
"setId": "b8d657ac-dbda-4455-8bb5-3896951c3b67",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b8d657ac-dbda-4455-8bb5-3896951c3b67",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b8d657ac-dbda-4455-8bb5-3896951c3b67"
}
],
"routes": [
"ORAL"
],
"labeler": "Alembic Pharmaceuticals Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "3 BLISTER PACK in 1 CARTON (46708-182-03) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK",
"package_ndc": "46708-182-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20161201"
}
],
"productId": "46708-182_052016e5-acea-4d2a-8d76-cef36eb99262",
"useDomain": "unknown",
"dosageForm": "TABLET, ORALLY DISINTEGRATING",
"productNdc": "46708-182",
"deaSchedule": null,
"genericName": "Zolmitriptan",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ZOLMITRIPTAN",
"strength": "5 mg/1"
}
],
"applicationNumber": "ANDA205074",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20161201",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175763",
"N0000175764",
"N0000175765"
],
"unii": [
"2FS66TH3YW"
],
"rxcui": [
"284201",
"351134"
],
"spl_set_id": [
"b8d657ac-dbda-4455-8bb5-3896951c3b67"
],
"pharm_class_epc": [
"Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]"
],
"pharm_class_moa": [
"Serotonin 1b Receptor Agonists [MoA]",
"Serotonin 1d Receptor Agonists [MoA]"
],
"manufacturer_name": [
"Alembic Pharmaceuticals Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:46708-182_052016e5-acea-4d2a-8d76-cef36eb99262"